HRP20191589T1 - Postupci za pripravu derivata galnac kiseline - Google Patents
Postupci za pripravu derivata galnac kiseline Download PDFInfo
- Publication number
- HRP20191589T1 HRP20191589T1 HRP20191589T HRP20191589T1 HR P20191589 T1 HRP20191589 T1 HR P20191589T1 HR P20191589 T HRP20191589 T HR P20191589T HR P20191589 T1 HRP20191589 T1 HR P20191589T1
- Authority
- HR
- Croatia
- Prior art keywords
- formula
- acid
- salt
- ester
- process according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/08—Polyoxyalkylene derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/20—Diazonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/10—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond
- C07C67/11—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with ester groups or with a carbon-halogen bond being mineral ester groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15180058 | 2015-08-06 | ||
| EP16745745.6A EP3331892B1 (en) | 2015-08-06 | 2016-08-02 | Processes for the preparation of galnac acid derivatives |
| PCT/EP2016/068361 WO2017021385A1 (en) | 2015-08-06 | 2016-08-02 | Processes for the preparation of galnac acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20191589T1 true HRP20191589T1 (hr) | 2019-12-13 |
Family
ID=54056068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20191589 HRP20191589T1 (hr) | 2015-08-06 | 2016-08-02 | Postupci za pripravu derivata galnac kiseline |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10597417B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3331892B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6940477B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102579520B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107709342B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016302697B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2982825C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2744437T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20191589T1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL256528B (cg-RX-API-DMAC7.html) |
| MX (1) | MX369556B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3331892T3 (cg-RX-API-DMAC7.html) |
| SI (1) | SI3331892T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017021385A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018215049A1 (en) * | 2017-05-23 | 2018-11-29 | F. Hoffmann-La Roche Ag | Process for galnac oligonucleotide conjugates |
| CA3085407A1 (en) * | 2018-01-26 | 2019-08-01 | F. Hoffmann-La Roche Ag | Radiolabelled oligonucleotides and process for their preparation |
| CN111699007A (zh) * | 2018-01-29 | 2020-09-22 | 豪夫迈·罗氏有限公司 | 用于制备GalNAc寡核苷酸缀合物的方法 |
| US11510939B1 (en) | 2019-04-19 | 2022-11-29 | Apellis Pharmaceuticals, Inc. | RNAs for complement inhibition |
| IL288116B2 (en) * | 2019-05-20 | 2025-03-01 | Hoffmann La Roche | Process for the preparation of galnac phosphoramidite epimers |
| CA3140410A1 (en) | 2019-06-20 | 2020-12-24 | Martin Edelmann | Radiolabeled moem type oligonucleotides and process for their preparation |
| CN110734372B (zh) * | 2019-09-30 | 2024-09-24 | 兰州交通大学 | 一种合成烯丙基脂肪醇聚氧乙烯醚羧酸(apea-9)的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US133170A (en) * | 1872-11-19 | Improvement in wheelbarrows | ||
| US156917A (en) * | 1874-11-17 | Improvement in car-couplings | ||
| US1185198A (en) * | 1912-11-25 | 1916-05-30 | Elliott Co | Tube-cleaning apparatus. |
| JP5004234B2 (ja) * | 2006-11-10 | 2012-08-22 | 独立行政法人産業技術総合研究所 | 膜マイクロドメイン又はコレステロール認識タンパク質検出用高感度分子プローブ |
| EA201170606A1 (ru) * | 2008-12-19 | 2011-12-30 | Пиннэкл Фармасьютикалс, Инк. | Феназопиридиновые соединения |
| CA3035532C (en) * | 2009-03-19 | 2021-10-26 | The Johns Hopkins University | Psma-targeting compounds and uses thereof |
| WO2011053614A1 (en) * | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Crystalline cdm-nag and methods for producing same |
| WO2011104169A1 (en) * | 2010-02-24 | 2011-09-01 | F. Hoffmann-La Roche Ag | Compositions for targeted delivery of sirna |
| HRP20200844T1 (hr) * | 2010-08-10 | 2020-08-21 | Takeda Pharmaceutical Company Limited | Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora |
| US8501930B2 (en) | 2010-12-17 | 2013-08-06 | Arrowhead Madison Inc. | Peptide-based in vivo siRNA delivery system |
| CN103492568B (zh) * | 2010-12-17 | 2017-04-12 | 箭头研究公司 | 用于siRNA的半乳糖簇‑药代动力学调节剂靶向部分 |
| HUE050394T2 (hu) | 2013-05-01 | 2020-11-30 | Ionis Pharmaceuticals Inc | Apolipoprotein(a) expressziójának módosítására szolgáló eljárások és készítmények |
| HRP20200163T1 (hr) | 2013-06-27 | 2020-08-07 | Roche Innovation Center Copenhagen A/S | Antisens oligomeri i konjugati koji ciljno djeluju na pcsk9 |
| RU2016122168A (ru) * | 2013-11-14 | 2017-12-19 | Рош Инновейшен Сентер Копенгаген А/С | Антисмысловые конъюгаты, направленные на аполипопротеин b |
| AU2015252895B2 (en) | 2014-05-01 | 2021-07-15 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulating angiopoietin-like 3 expression |
-
2016
- 2016-08-02 EP EP16745745.6A patent/EP3331892B1/en active Active
- 2016-08-02 CA CA2982825A patent/CA2982825C/en active Active
- 2016-08-02 PL PL16745745T patent/PL3331892T3/pl unknown
- 2016-08-02 KR KR1020177036266A patent/KR102579520B1/ko active Active
- 2016-08-02 HR HRP20191589 patent/HRP20191589T1/hr unknown
- 2016-08-02 SI SI201630375T patent/SI3331892T1/sl unknown
- 2016-08-02 CN CN201680038736.5A patent/CN107709342B/zh active Active
- 2016-08-02 ES ES16745745T patent/ES2744437T3/es active Active
- 2016-08-02 JP JP2018502203A patent/JP6940477B2/ja active Active
- 2016-08-02 WO PCT/EP2016/068361 patent/WO2017021385A1/en not_active Ceased
- 2016-08-02 AU AU2016302697A patent/AU2016302697B2/en active Active
- 2016-08-02 MX MX2017015662A patent/MX369556B/es active IP Right Grant
-
2017
- 2017-12-24 IL IL256528A patent/IL256528B/en active IP Right Grant
-
2018
- 2018-02-06 US US15/890,181 patent/US10597417B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3331892B1 (en) | 2019-07-03 |
| WO2017021385A1 (en) | 2017-02-09 |
| IL256528B (en) | 2020-01-30 |
| AU2016302697A1 (en) | 2017-10-26 |
| KR102579520B1 (ko) | 2023-09-15 |
| EP3331892A1 (en) | 2018-06-13 |
| CN107709342B (zh) | 2021-09-03 |
| US20180162894A1 (en) | 2018-06-14 |
| CN107709342A (zh) | 2018-02-16 |
| CA2982825C (en) | 2023-10-17 |
| KR20180030783A (ko) | 2018-03-26 |
| HK1250717A1 (zh) | 2019-01-11 |
| IL256528A (en) | 2018-02-28 |
| MX2017015662A (es) | 2018-04-18 |
| BR112017021926A2 (pt) | 2018-07-03 |
| JP2018523643A (ja) | 2018-08-23 |
| PL3331892T3 (pl) | 2019-11-29 |
| US10597417B2 (en) | 2020-03-24 |
| ES2744437T3 (es) | 2020-02-25 |
| JP6940477B2 (ja) | 2021-09-29 |
| MX369556B (es) | 2019-11-12 |
| SI3331892T1 (sl) | 2019-10-30 |
| CA2982825A1 (en) | 2017-02-09 |
| AU2016302697B2 (en) | 2020-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20191589T1 (hr) | Postupci za pripravu derivata galnac kiseline | |
| JP2018523643A5 (cg-RX-API-DMAC7.html) | ||
| JP6850282B2 (ja) | N−(4−フルオロベンジル)−n−(1−メチルピペリジン−4−イル)−n’−(4−(2−メチルプロピルオキシ)フェニルメチル)カルバミドならびにその酒石酸塩および多形形態cを調製する方法 | |
| DE69937076T2 (de) | Zwischenprodukte für die Herstellung von Imidazo-Pyridin-Derivate | |
| MXPA05008450A (es) | Procesos para la preparacion de n-heteroaril-n-aril-aminas mediante reaccion de un ester de acido n-aril-carbamico con un halo-heteroarilo y procesos analogos. | |
| CA2751548C (en) | Synthesis of (4as,7as)-octahydro-1h-pyrrolo[3,4-b]pyridine | |
| JP2004523529A5 (cg-RX-API-DMAC7.html) | ||
| US8664398B2 (en) | Moxifloxacin hydrochloride compounds and intermediates and methods for making same | |
| HRP20201480T1 (hr) | Derivati indolinona i postupak za njihovu proizvodnju | |
| HRP20150700T1 (hr) | Postupak za pripravu bifenil-2-il karbaminske kiseline | |
| CA2914381A1 (en) | An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine | |
| EP0657448A1 (de) | Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten | |
| HRP20211816T1 (hr) | Postupak za pripravu [7-[[4-fenil-5-alkoksikarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il]metil]-3-okso-5,6,8,8a-tetrahidro-1h-imidazo[1,5-a]pirazin-2-l]alkila karboksilne kiseline | |
| JP2004522718A5 (cg-RX-API-DMAC7.html) | ||
| CN103232369B (zh) | 一种芴甲氧羰酰谷氨酸-5-叔丁酯的制备方法 | |
| JP2008515793A5 (cg-RX-API-DMAC7.html) | ||
| CN101098851A (zh) | β-烷氧基丙酰胺类、溶剂、洗涤剂和液态药物组合物以及β-烷氧基丙酰胺类的制备方法 | |
| ZA200207204B (en) | Shortened synthesis of 3,3-diarylpropylamine derivatives. | |
| HRP20120071T1 (hr) | (1-AZA-BICIKLO[3.3.1]NON-4-IL)-[5-(1H-INDOL-5-IL)-HETEROARIL]-AMINI KAO KOLINERGIČKI LIGANDI OD N-AChR ZA LIJEČENJE PSIHOTIČKIH I NEURODEGENERATIVNIH POREMEĆAJA | |
| CN102712572B (zh) | 一种用于获得 3,3-二苯基丙胺的方法 | |
| CN104610359A (zh) | 一种制备磷酸特地唑胺的关键中间体及其制备方法 | |
| CN102675313A (zh) | 一种盐酸莫西沙星的制备方法 | |
| HRP20110093T1 (hr) | Kristalna baza escitaloprama i orodisperzibilne tablete koje sadrže bazu escitaloprama | |
| HRP20211636T1 (hr) | Postupak sinteze međuprodukata nebivolola | |
| KR20160001054A (ko) | 술폰산 또는 술폰산염 촉매를 이용한 에스테르 화합물의 제조방법 |